Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates-Reference-Cited by-同舟云学术

Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates

Published:2018-08-07 Issue:6 Volume:16 Page:803-817
ISSN:1175-5652
Container-title:Applied Health Economics and Health Policy
language:en
Short-container-title:Appl Health Econ Health Policy

Author:

Espin Jaime^ORCID,Schlander Michael,Godman Brian^ORCID,Anderson Pippa^ORCID,Mestre-Ferrandiz Jorge^ORCID,Borget Isabelle^ORCID,Hutchings Adam,Flostrand Steven,Parnaby Adam,Jommi Claudio^ORCID

Funder

See Conflict of Interest Form

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics and Econometrics,General Medicine

Link

http://link.springer.com/article/10.1007/s40258-018-0419-1/fulltext.html

Reference73 articles.

1. Newhouse JP. Medical care costs: how much welfare loss? J Econ Perspect. 1992;6:3–21.

2. Drummond M, Jonsson B. Moving beyond the drug budget silo mentality in Europe. Value Health. 2003. https://doi.org/10.1046/j.1524-4733.6.s1.8.x/full .

3. OECD. Pharmaceutical spending (indicator). 2018. https://doi.org/10.1787/998febf6-en . Accessed 5 Jul 2018.

4. OECD. Ensuring health system sustainability and access to innovation. http://www.oecd.org/health/health-systems/Ensuring-health-system-sustainability-and-access-to-innovation.pdf . Accessed 1 Aug 2018.

5. OECD. Pharmaceuticals. http://www.oecd.org/els/health-systems/pharmaceuticals.htm . Accessed 1 Aug 2018.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting the pharmaceutical needs of hospitals using machine learning algorithms;International Journal of Data Science and Analytics;2024-04-15

2. Values, challenges, and responses associated with high-priced potential cures: perspectives of diverse stakeholders in South Korea;Cost Effectiveness and Resource Allocation;2024-03-04

3. Prices of Orphan Drugs in Four Western European Countries Before and After Market Exclusivity Expiry: A Cross-Country Comparison of List Prices and Purchase Prices;Applied Health Economics and Health Policy;2023-09-26

4. Exploring the effectiveness of demand-side retail pharmaceutical expenditure reforms;International Journal of Health Economics and Management;2022-09-21

5. Public health policies for the common interest: rethinking EU states’ incentives strategies when a pandemic reshuffles all interests;The European Journal of Health Economics;2021-07-05